Author

Jingyi Tang

Institutions: Chongqing University, Chongqing Cancer Hospital, Chongqing University of Technology

Observed institutions: Chongqing University, Chongqing Cancer Hospital, Chongqing University of Technology

ORCID: 0009-0002-0841-0795

Observed ORCID: 0009-0002-0841-0795

OpenAlex ID: A5126967471

Epigenetic Silencing of CYYR1 Promotes Lung Adenocarcinoma Progression Through TRIM21‐Dependent Regulation of HMMR Stability

2026 · Fengsheng Dai, Jingyi Tang, et al. · Advanced Science

TET2: a critical regulatory hub with broad therapeutic implications across human diseases

2026 · Jingyi Tang, Ruoxian Wang, et al. · Frontiers in Immunology

Development and validation of an 11-CpG methylation signature-based nomogram for predicting prognosis in early-onset breast cancer

2026 · Jingyi Tang, Yan Li, et al. · Translational Cancer Research

Works count: 3

Citation count:

H-index:

I10-index: